OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces that it has reached agreement to launch its own brands
OptiBiotix Health shares: brief investment case overview
OPTI shares have soared in July. Is it too late to get in, or is the company just getting started?
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 25th July 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Actual, Aferian, Bradda,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 24th July 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Canadian, Cleantech, Caracal Gold,
OptiBiotix Health (AIM:OPTI) Launch of GoFigure products on Tmall China
Launch of GoFigure products on Tmall China
OptiBiotix Health (AIM:OPTI) Trading Update
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular diseaseanddiabetes, provides the following unaudited trading update ahead of the Group’s half year results for
OptiBiotix Health (AIM:OPTI) ProBiotix Health – Appointment of CEO
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, notes the announcement (14 June 2022) by ProBiotix Health plc